Cost per insertion and couple year of protection for postpartum intrauterine devices and implants provided during service scale-up in Kigali, Rwanda
Open Access
- 28 February 2020
- journal article
- Published by F1000 Research Ltd in Gates Open Research
Abstract
Introduction: In two high-volume government hospitals, their two affiliated health facilities, and two additional health facilities, we developed and implemented postpartum intrauterine device (PPIUD) and postpartum (PP) implant promotional counseling and service delivery procedures between May-July 2017 in Kigali, Rwanda. Between August 2017 and July 2018, 9,073 pregnant women received PPIUD/PP implant promotions who later delivered in one of our selected facilities. Of those, 2,633 had PPIUDs inserted, and 955 had PP implants inserted. The goal of the present analysis is to detail implementation expenditures and estimate incremental costs per insertion and couple years of protection (CYP) for PPIUD and PP implant users. Methods: We detail the incremental costs during the implementation from the health system perspective (including both the implementation costs and the cost of contraceptive methods) and use of standard methods to estimate the cost per insertion and CYP for PPIUD and PP implant users. In addition to the incremental costs of labor and supplies, the costs of promotional activities are included. Research costs for formative work were excluded. Results: A total of $74,147 USD was spent on the implementation between August 2017 and July 2018. The largest expense (34% of total expenses) went toward personnel, including doctoral-level, administrative, data management and nurse counseling staff. Training for PPIUD and implant providers and promoters comprised 8% of total expenses. Recruitment and reimbursements comprised 6% of expenses. Costs of implants to the government comprised 12% of the expenses, much higher than the cost of IUDs (1%). Costs per insertion were $25/PPIUDs and $77/PP implant. Costs per CYP were $6/PPIUDs and $21/PP implant. Conclusion: Understanding the cost per PPIUD/PP implant inserted and CYP can help to inform the cost of scaling up PPIUD/PP implant service implementation activities and resource allocation decision-making by the Rwandan Ministry of Health.Funding Information
- Centers for Disease Control and Prevention (GH15-1616, 5NU2GGH001443)
- International AIDS Vaccine Initiative (SOW2166)
- Bill and Melinda Gates Foundation (OPP1160661)
- National Institutes of Health (K01MH107320, NIAID R01 AI51231, NIAIDR01AI64060, 5D43TW001042, NIAIDR37AI51231)
- United States Agency for International Development
- Emory University
- Center for AIDS Research, Emory University (P30AI050409)
- University Research Committee, Emory University (URCGA16872456)
- National Institutes of Health (K01MH107320, NIAID R01 AI51231, NIAIDR01AI64060, 5D43TW001042, NIAIDR37AI51231)
This publication has 32 references indexed in Scilit:
- Reviewing the cost-effectiveness of long-acting reversible contraceptive methods in an Australian contextAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2018
- LARC methods: entering a new age of contraception and reproductive healthContraception and Reproductive Medicine, 2016
- Missed opportunities for family planning: an analysis of pregnancy risk and contraceptive method use among postpartum women in 21 low- and middle-income countriesContraception, 2015
- Immediate postpartum insertion of intrauterine device for contraceptionEmergencias, 2015
- Postpartum contraceptive use and unmet need for family planning in five low-income countriesReproductive Health, 2015
- Intrauterine device insertion in the postpartum period: A systematic reviewThe European Journal of Contraception & Reproductive Health Care, 2014
- Barriers to Intrauterine Device Uptake in a Rural Setting in GhanaHealth Care for Women International, 2013
- Fertility goal-based counseling increases contraceptive implant and IUD use in HIV-discordant couples in Rwanda and ZambiaContraception, 2013
- The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guidelineHuman Reproduction, 2008
- Effects of preceding birth intervals on neonatal, infant and under‐five years mortality and nutritional status in developing countries: evidence from the demographic and health surveysInternational Journal of Gynecology & Obstetrics, 2005